Proceeds to support commercialization of GenomicsNext™ – a first-of-its-kind liquid biopsy platform bringing fast, reliable gene expression quantitation to cell-free DNA blood samples to provide deeper insight beyond DNA mutations Durham, N.C., June 18, 2025 – GeneCentric Therapeutics, a company making precision medicine more precise through gene expression, today announced the initial closing of an … Continue reading GeneCentric Announces Series C Financing to Advance Novel Liquid Biopsy Platform for Precision Oncology